18 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
, or injected; expanded eligibility criteria for Medicaid programs; creates a new Patient-Centered Outcomes Research Institute to oversee, identify priorities
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research; and established a Center
8-K
EX-2.1
SQZB
SQZ Biotechnologies Co
22 Dec 23
Entry into a Material Definitive Agreement
5:18pm
Authority” means any Government Entity having authority to monitor, oversee, impose, determine, or collect any Tax.
“Tax Return” means any return
8-K
EX-99.1
SQZB
SQZ Biotechnologies Co
30 Nov 22
Cost Associated with Exit or Disposal Activities
4:32pm
. Bernstein, along with Chief Medical Officer, Marshelle Smith Warren, MD, will oversee the advancement of the eAPC program and clinical trial.
“The Board
10-K
75j0wn1ygugns4vb6 i3
18 Mar 21
Annual report
6:31am
424B4
2hl4ipt l9
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
3wr3ueuwv
1 Feb 21
Draft registration statement
12:00am
10-Q
ia4v9 1dpqe5xvefs
10 Dec 20
Quarterly report
4:46pm
424B4
b2a5lwntuit6d9p2x
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
EX-10.7
8q19h12xjvbvk7bapd
9 Oct 20
IPO registration
4:59pm
S-1
zrdtae
9 Oct 20
IPO registration
4:59pm
DRS/A
u0iqt6qeszvg4t0byf
25 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
cz9mg593dn1gv
28 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
igw97 qd2njtn
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
yarojpvvid 8c
21 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next